ArticlePharmaceutics2024

Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia.

Joana Pereira-Vieira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.